Associations between visceral adipose index and stress urinary incontinence among US adult women: a cross-sectional study - Top-Institutions - MDSpire

Associations between visceral adipose index and stress urinary incontinence among US adult women: a cross-sectional study

  • By

  • Haigang Pang

  • Yuxin Yin

  • Juan Xue

  • Xi Chen

  • Jian Pang

  • Jinping Zhang

  • Yi Sun

  • November 3, 2023

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urogynecology
    • Obstetrics and Gynecology
    • Endocrinology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Urogynecology
    • Obstetrics and Gynecology
    • Metabolic Medicine

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urogynecology
    • Women's Health Research
    • Obesity Medicine

  • #4

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Urogynecology
    • Endocrinology
    • Epidemiology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urogynecology
    • Obstetrics and Gynecology
    • Metabolic Research

Original Source(s)

Associations between visceral adipose index and stress urinary incontinence among US adult women: a cross-sectional study

  • by Haigang Pang, Yuxin Yin, Juan Xue, Xi Chen, Jian Pang, Jinping Zhang, Yi Sun

  • November 3, 2023

Related Content

Association between kidney stones and life's essential 8: a population-based study

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.

Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies